Ark. High Court Overturns J&J's $1.2B Risperdal Fine
Johnson & Johnson and a subsidiary on Thursday dodged a more than $1.2 billion fine over their marketing of the antipsychotic drug Risperdal when the Arkansas Supreme Court found that the...To view the full article, register now.
Already a subscriber? Click here to view full article